← All organizations

Shenzhen Institute for Innovation and Translational Medicine

Academic/Hospital

Also known as: Shenzhen Institute for Innovation and Translational Medicine

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2017

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 4 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

anti-ny eso-1 tcr-transduced t cells

Indications

Studied for

Recent trials (6)

NCT03191773Study directorPhase 1/Phase 2Jun 30, 2017
NCT03191773CollaboratorPhase 1/Phase 2Jun 30, 2017
NCT03076437Overall official - principal investigatorPhase 1/Phase 2Jan 15, 2016
NCT03076437Lead sponsorPhase 1/Phase 2Jan 15, 2016
NCT02456350CollaboratorPhase 1Apr 1, 2015
NCT02457650CollaboratorPhase 1Apr 1, 2015

Details

Last known activity: Jun 30, 2017